Study shows Wellmune® reduces duration of cold/flu symptoms for highly stressed adults.
Study: Medical Students
Lifestyle stress has been shown to suppress the immune system, putting otherwise healthy individuals at risk—especially during cold-and-flu season. In this study, Wellmune demonstrated a strong trend towards reducing the duration of upper respiratory tract infection (URTI) symptoms for medical students.
Study Protocol
| Study Site | University of Southampton School of Medicine, UK |
| Population | 97 fourth-year medical school students |
| Age | 18-65 (average 21 years) |
| Design | Randomized, double-blinded, placebo-controlled, parallel arm study |
| Duration | 90 days |
| Serving |
Participants were split into two groups, and consumed one of the following once daily:
|
| Details |
Participants completed a daily health diary recording presence or absence of URTI symptoms. Two or more reported symptoms for two consecutive days triggered a medical assessment and cytokine analysis within 24 hours. 24 episodes of URTIs were medically confirmed; 12 in each group. |
Results
- Participants taking Wellmune experienced a significant reduction in URTI symptoms.
- Wellmune did not stimulate the immune system with inflammatory cytokines when subjects were not experiencing a URTI.
Participants taking Wellmune had an 18% reduction in the total days with URTI symptoms compared to placebo.
Prevamune™ contains the clinical strength of Wellmune® used in scientific studies.
